Dr Richard Furie-> Obinutuzumab for proliferative #lupus nephritis -Compared to rituximab, has more B-cell depletion in tissue and #SLE patients -Meaningful benefits over SOC alone on renal response through week 104. -Phase 3 REGENCY pending. #ACR20 #ACRambassador #Rheumatology https://t.co/aPi1yueAiV